This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
DESCRIPTION. This is an update of the 2002 US Preventive Services Task Force recommendation on screening for child and adolescent major depressive disorder.
METHODS. The US Preventive Services Task Force weighed the benefits and harms of screening and treatment for major depressive disorder in children and adolescents, incorporating new evidence addressing gaps in the 2002 recommendation statement. Evidence examined included the benefits and harms of screening, the accuracy of primary care–feasible screening tests, and the benefits and risks of treating depression by using psychotherapy and/or medications in patients aged 7 to 18 years.
RECOMMENDATIONS. Screen adolescents (12–18 years of age) for major depressive disorder when systems are in place to ensure accurate diagnosis, psychotherapy (cognitive-behavioral or interpersonal), and follow-up (B recommendation). Evidence is insufficient to warrant a recommendation to screen children (7–11 years of age) for major depressive disorder (I statement).
- Accepted August 7, 2008.
- Copyright © 2009 by the American Academy of Pediatrics
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Purchase access
In this issue
Jump to section
Related Articles
Cited By...
- Understanding Adolescent Expressions of Sadness: A Qualitative Exploration
- Increasing Access to Mental Health Services Through Reduction of Stigma
- Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part I. Practice Preparation, Identification, Assessment, and Initial Management
- Identifying Targets for Improving Mental Healthcare of Adolescents with Systemic Lupus Erythematosus: Perspectives from Pediatric Rheumatology Clinicians in the United States and Canada
- International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety
- Major Depressive Disorder and Bipolar Disorder Predispose Youth to Accelerated Atherosclerosis and Early Cardiovascular Disease: A Scientific Statement From the American Heart Association
- Depression and Suicide in Children and Adolescents
- Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: results of The International Depression Epidemiological Study across nine countries
- Cardiovascular Disease Risk Factors in Youth With Diabetes Mellitus: A Scientific Statement From the American Heart Association
- Improving Depression Screening for Adolescents With Type 1 Diabetes
- Evidence for the Management of Adolescent Depression
- Efficacy of Metabolic and Psychological Screening for Mood Disorders Among Children With Type 1 Diabetes
- Evidence-based clinical guidelines for immigrants and refugees
- Pediatric and Adolescent Mental Health Emergencies in the Emergency Medical Services System
- Development, Validation, and Utility of Internet-Based, Behavioral Health Screen for Adolescents
- Evaluation of the PHQ-2 as a Brief Screen for Detecting Major Depression Among Adolescents
- Standardized Screening for Suicidal Adolescents in Primary Care
- Prevalence and Correlates of Internalizing Mental Health Symptoms Among CSHCN
- USPSTF: Screening Children and Adolescents for Depression